glp 1 agonist in heart failure Impact of GLP-1 receptor agonists on cardiovascular outcomes with preserved ejection fraction (HFpEF): systematic review and meta-analysis | Clinical Research in Cardiology GLP-1 receptor agonist-based therapies and
Description
Complementary analyses using a Fine and Gray model and separate application of a cause specific hazard model with time varying inverse probability-of-death censoring weights yielded consistent results (supplementary figure S7)
How much weight can I expect to lose on the medicine
Science 313 , 670673 (2006)
Detection and kinetic behavior of preproinsulin in pancreatic islets
Health literacy will help us make informed decisions about our treatment options
